Nautilus Biotechnolgy
NAUT
NAUT
73 hedge funds and large institutions have $123M invested in Nautilus Biotechnolgy in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 25 increasing their positions, 16 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
10% less funds holding
Funds holding: 81 → 73 (-8)
54% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 13
100% less call options, than puts
Call options by funds: $1K | Put options by funds: $1.83M
Holders
73
Holding in Top 10
3
Calls
$1K
Puts
$1.83M
Top Buyers
| 1 | +$1.84M | |
| 2 | +$413K | |
| 3 | +$204K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$163K |
| 5 |
VCWA
Vanguard Capital Wealth Advisors
Denver,
Colorado
|
+$145K |
Top Sellers
| 1 | -$1.35M | |
| 2 | -$1.08M | |
| 3 | -$809K | |
| 4 |
DCMIC
Decheng Capital Management III (Cayman)
Grand Cayman,
Cayman Islands
|
-$540K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$522K |